Barekatain Mahta, Johansson Linda C, Lam Jordy H, Chang Hao, Sadybekov Anastasiia V, Han Gye Won, Russo Joseph, Bliesath Joshua, Brice Nicola L, Carlton Mark B L, Saikatendu Kumar S, Sun Hukai, Murphy Sean T, Monenschein Holger, Schiffer Hans H, Popov Petr, Lutomski Corinne A, Robinson Carol V, Liu Zhi-Jie, Hua Tian, Katritch Vsevolod, Cherezov Vadim
Bridge Institute, USC Michelson Center for Convergent Biosciences, University of Southern California, Los Angeles, CA 90089, USA.
Department of Chemistry, University of Southern California, Los Angeles, CA 90089, USA.
Sci Signal. 2024 Dec 3;17(865):eado8741. doi: 10.1126/scisignal.ado8741.
GPR6 is an orphan G protein-coupled receptor with high constitutive activity found in D2-type dopamine receptor-expressing medium spiny neurons of the striatopallidal pathway, which is aberrantly hyperactivated in Parkinson's disease. Here, we solved crystal structures of GPR6 without the addition of a ligand (a pseudo-apo state) and in complex with two inverse agonists, including CVN424, which improved motor symptoms in patients with Parkinson's disease in clinical trials. In addition, we obtained a cryo-electron microscopy structure of the signaling complex between GPR6 and its cognate G heterotrimer. The pseudo-apo structure revealed a strong density in the orthosteric pocket of GPR6 corresponding to a lipid-like endogenous ligand. A combination of site-directed mutagenesis, native mass spectrometry, and computer modeling suggested potential mechanisms for high constitutive activity and inverse agonism in GPR6 and identified a series of lipids and ions bound to the receptor. The structures and results obtained in this study could guide the rational design of drugs that modulate GPR6 signaling.
GPR6是一种孤儿G蛋白偶联受体,具有高组成性活性,存在于纹状体苍白球通路中表达D2型多巴胺受体的中型多棘神经元中,在帕金森病中该受体异常过度激活。在此,我们解析了未添加配体时GPR6的晶体结构(一种假无配体状态)以及与两种反向激动剂形成的复合物的晶体结构,其中包括CVN424,该药物在临床试验中改善了帕金森病患者的运动症状。此外,我们还获得了GPR6与其同源G异源三聚体之间信号复合物的冷冻电镜结构。假无配体结构显示GPR6的正构口袋中有一个与类脂内源性配体相对应的强电子密度。定点诱变、天然质谱和计算机建模相结合,揭示了GPR6高组成性活性和反向激动作用的潜在机制,并确定了一系列与该受体结合的脂质和离子。本研究获得的结构和结果可为调节GPR6信号传导的药物合理设计提供指导。